SFG
CLB icon

SevenBridge Financial Group’s Core Laboratories CLB Stock Holding History

SevenBridge Financial Group’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-100
Closed -$12K – 648
2017
Q1 		$12K Hold
100
– – 0.01% 414
2016
Q4 		$11K Hold
100
– – 0.01% 429
2016
Q3 		$11K Hold
100
– – 0.01% 424
2016
Q2 		$12K Buy
+100
New +$12.1K 0.01% 487

Other funds holding CLB

ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SGA
Sustainable Growth Advisers Stamford, Connecticut $10.2B AUM 1.48% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
WP
Wedgewood Partners St Louis, Missouri $484M AUM 16.04% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

SevenBridge Financial Group's CLB Position: Q2 2017 in Review

SevenBridge Financial Group sold out of Core Laboratories (CLB) in Q2 2017, closing a stake of 100 shares — an estimated $12K sold.

SevenBridge Financial Group first reported a position in CLB in Q2 2016 and held it in 4 quarters. The position peaked at $12K in Q1 2017. 360 funds tracked by Wall St. Rank hold CLB as of Q2 2017.

  • SevenBridge Financial Group reported no remaining Core Laboratories position as of Q2 2017 after selling out during the quarter.
  • SevenBridge Financial Group sold 100 Core Laboratories shares in Q2 2017, an estimated $12K.
  • SevenBridge Financial Group first reported a position in Core Laboratories in Q2 2016 and held it in 4 quarters.
  • SevenBridge Financial Group's Core Laboratories position peaked at $12K in Q1 2017.
  • 360 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2017.

Based on SevenBridge Financial Group's 13F filing for Q2 2017, filed 14 Aug 2017.